Schrodinger

Founders Richard Friesner William Goddard

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 8
Average round size
info
The average size of a deal this fund participated in
$42M
Portfolio companies 5
Rounds per year 0.25
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.38
Exits 1
Key employees Soon

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Alternative Medicine
Summary

Schrodinger is the famous Corporate Investor, which was founded in 1990. The leading representative office of defined Corporate Investor is situated in the New York. The fund was located in North America if to be more exact in United States.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Therapeutics, Health Care. Among the most popular portfolio startups of the fund, we may highlight Nimbus Therapeutics, Morphic Therapeutic. The fund has no exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.

The typical case for the fund is to invest in rounds with 5 participants. Despite the Schrodinger, startups are often financed by Bill Gates, Atlas Venture, SR One. The meaningful sponsors for the fund in investment in the same round are Timothy A. Springer, SR One, Polaris Partners. In the next rounds fund is usually obtained by SR One, Pfizer Venture Investments, Bill Gates.

The fund was created by Richard Friesner, William Goddard.

The increased amount of exits for fund were in 2019. Comparing to the other companies, this Schrodinger performs on 4 percentage points less the average number of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year. The important activity for fund was in 2016.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Accelerated Growth Partners -
Beijing Guoyou Ziben Beijing, Beijing, China
BMO Harris Bank Chicago, Illinois, United States
Development Principles Fund China, Hong Kong, Hong Kong Island
Fondazione Golinelli Bologna, Emilia-Romagna, Italy
FundFire New York, New York, United States
GCM Grosvenor Chicago, Illinois, United States
Ikemori Venture Support Japan, Tokyo
Juesheng.com China, Dongcheng, Shaanxi
Mithras Capital Partners England, London, United Kingdom
Nanwang Ziben China, Guangdong, Guangzhou
Propeler Distrito Federal, Mexico, Mexico City
Purdue Foundry Indiana, United States, West Lafayette
RockTree Capital New York, New York, United States
Tower Three Partners Connecticut, Greenwich, United States
Vidinovo -
XN Capital -
ZNJ Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ShouTi

Biotechnology
Health Care
Medical
Pharmaceutical
Product Research
$100M20 Oct 2021 Shanghai, China

Ajax Therapeutics

Biotechnology
Life Science
Medical
$40M01 Jun 2021 Cambridge, Massachusetts, United States

Bright Angel Therapeutics

Biotechnology
03 Dec 2019 Old Toronto, Ontario, Canada

Morphic Therapeutic

Biotechnology
Health Care
Medical
Therapeutics
$80M25 Sep 2018 Massachusetts, United States

Nimbus Therapeutics

Alternative Medicine
Biotechnology
Health Care
Therapeutics
$65M05 Jun 2018 Cambridge, Massachusetts, United States

Morphic Therapeutic

Biotechnology
Health Care
Medical
Therapeutics
$51M30 Jun 2016 Massachusetts, United States

Morphic Therapeutic

Biotechnology
Health Care
Medical
Therapeutics
$3M01 Jan 2016 Massachusetts, United States

Nimbus Therapeutics

Alternative Medicine
Biotechnology
Health Care
Therapeutics
$3M29 Apr 2010 Cambridge, Massachusetts, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Schrodinger?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: